Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 5/20 | 0.36 |
| ▸ | CA7 | P43166 | 5/20 | 0.36 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | WDR5 | P61964 | 1/20 | 0.34 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL759879 | 0.98 | TYMS (0.51) | TYMSCA12CA7CA1CA4 | |
| SCHEMBL2434561 | 0.85 | TYMS (0.53) | TYMSCA12CA7CA1CA4 | |
| SCHEMBL475904 | 0.81 | TYMS (0.61) | TYMSCA12CA7CA1CA4 | |
| SCHEMBL202564 | 0.77 | CYP1A2 (0.50) | CA12CA7CA1CA4MAPT | |
| SCHEMBL11350894 | 0.76 | TYMS (0.47) | TYMSCA12CA7CA1CA4 | |
| SCHEMBL18338732 | 0.76 | ALDH1A1 (0.50) | TYMSCA12CA7CA1CA4 | |
| SCHEMBL48997 | 0.75 | CYP1A2 (0.52) | CA12CA7CA1CA4MAPT | |
| SCHEMBL29420737 | 0.75 | CYP1A2 (0.52) | CA12CA7CA1CA4MAPT | |
| SCHEMBL25187023 | 0.73 | TYMS (0.51) | TYMSCA12CA7CA1CA4 | |
| SCHEMBL6541546 | 0.73 | TYMS (0.51) | TYMSCA12CA7CA1CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10577725-B2 | Fiber and fiber structure | TEIJIN LIMITED (JP) | 2020-03-03 | — | — | US | disclosed |
| EP-2374833-B1 | METHOD FOR USING CYCLIC CARBODIIMIDE | TEIJIN LTD (JP) | 2017-12-06 | — | — | EP | disclosed |
| US-9758496-B2 | Method of using a cyclic carbodiimide | TEIJIN LIMITED (JP) | 2017-09-12 | — | — | US | disclosed |
| EP-2380883-B1 | CYCLIC CARBODIIMIDE COMPOUNDS | TEIJIN LTD (JP) | 2015-12-02 | — | — | EP | disclosed |
| US-8987440-B2 | Cyclic carbodiimide compounds | TEIJIN LIMITED (JP) | 2015-03-24 | — | — | US | disclosed |
| EP-2479320-B1 | FIBER AND FIBER STRUCTURE | TEIJIN LTD (JP) | 2015-02-25 | — | — | EP | disclosed |
| CN-102245585-B | Cyclic carbodiimide compound | TEIJIN LTD | 2014-12-17 | — | — | CN | disclosed |
| CN-102320977-B | Cyclic carbodiimide compounds | TEIJIN LTD | 2014-11-12 | — | — | CN | disclosed |
| EP-2581368-A1 | CYCLIC CARBODIIMIDE COMPOUND | Teijin Limited (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-20130079510-A1 | CYCLIC CARBODIIMIDE COMPOUND | TEIJIN LIMITED (JP) | 2013-03-28 | — | — | US | disclosed |
| EP-2479320-A1 | FIBER AND FIBER STRUCTURE | Teijin Limited (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120184166-A1 | FIBER AND FIBER STRUCTURE | TEIJIN LIMITED (JP) | 2012-07-19 | — | — | US | disclosed |
| CN-102597344-A | Fiber and fiber structure | TEIJIN LTD | 2012-07-18 | — | — | CN | disclosed |
| CN-102320977-A | The ring-type carbodiimide compound | TEIJIN LTD | 2012-01-18 | — | — | CN | disclosed |
| CN-102320976-A | The ring-type carbodiimide compound | TEIJIN LTD | 2012-01-18 | — | — | CN | disclosed |
| CN-102245585-A | Cyclic carbodiimide compound | TEIJIN LTD | 2011-11-16 | — | — | CN | disclosed |
| EP-2380883-A1 | CYCLIC CARBODIIMIDE COMPOUNDS | Teijin Limited (JP) | 2011-10-26 | — | — | EP | disclosed |
| US-20110251384-A1 | CYCLIC CARBODIIMIDE COMPOUNDS | TEIJIN LIMITED (JP) | 2011-10-13 | — | — | US | disclosed |
| EP-2374833-A1 | METHOD FOR USING CYCLIC CARBODIMIDE | Teijin Limited (JP) | 2011-10-12 | — | — | EP | disclosed |
| US-20110237755-A1 | METHOD OF USING A CYCLIC CARBODIIMIDE | TEIJIN LIMITED (JP) | 2011-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251384-A1 | CYCLIC CARBODIIMIDE COMPOUNDS | APEX1, LIG4, EPB41 | TYMS 1991/4885CA12 3252/4885CA7 1651/4885 |
| US-20130079510-A1 | CYCLIC CARBODIIMIDE COMPOUND | CNOT9, CNOT1, ARPC4 | TYMS 2365/4885CA12 1709/4885CA7 1705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.